METASTASIS RESEARCH SOCIETY INC H … - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

RAJEEV SAMANT

Phone

8134541637

Tax Period

2024-01-01 to 2024-12-31

METASTASIS RESEARCH SOCIETY INC H LEE MOFFITT CANCER CENTER, founded in 2017, is a small nonprofit in the Medical Research sector that reported $159K in total revenue in fiscal year 2024. Revenue surged 351% from the prior year, signaling strong growth momentum.

Mission

TO PROMOTE AND ADVANCE CANCER TREATMENTS, RESEARCH AND INFORMATION ON CANCER.

Program Service Accomplishments

Program 1

Expenses: $169,718

TO PROMOTE AND ADVANCE CANCER TREATMENTS, RESEARCH AND INFORMATION ON CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $158,889

Program Service Revenue $0

Investment Income $23

Other Revenue $0

TOTAL REVENUE $158,912

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $169,718

Other Expenses $169,718

TOTAL EXPENSES $169,718

Year-over-Year Comparison

	2024	2023	Change
Revenue	$158,912	$35,273	+3.5%
Expenses	$169,718	$25,294	+5.7%
Net Income	$-10,806	$9,979	-2.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ERIK SAHAI	PRESIDENT	5.00	Officer	$0	$0	$0
ALANA WELM	VICE PRESIDENT	5.00	Officer	$0	$0	$0
RAJEEV SAMANT	TREASURER	5.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$158,912	$169,718	$195,082	$-10,806
2023	$35,273	$25,294	$205,888	$9,979
2022	$77,541	$165,498	$195,909	$-87,957
2021	$69,932	$33,206	$283,866	$36,726
2020	$72,437	$6,085	$247,140	$66,352
2019	$17,082	$85,088	$180,789	$-68,006
2018	$371,110	$291,532	$248,794	$79,578

METASTASIS RESEARCH SOCIETY INC H LEE MOFFITT CANCER CENTER